Despite a preliminary theory that health insurers could potentially hold too much buyer power, resulting in a loss of quality of consulting and preventative care for consumers, the Competition Commission has expressed support of health insurers in its most recent update of a widespread probe into the UK’s private healthcare sector. A common complaint, according to reports, often involves Bupa, one of the UK’s largest private medical insurers; the CC has received complaints that the insurer’s fee schedule reduces consultation quality and hinders innovation. The Commission has said it has “not seen evidence” of these claims, however. While its update did not come down hard on insurers, the Commission did suggest that there may be cause for concern within the private hospital operators’ sector.
Featured News
Age-Restriction Laws Are Proliferating; So Too Are the Difficult Tradeoffs Policymakers Face
Dec 23, 2025 by
CPI
Federal AI Strategy Raises Compliance Stakes for Banks and Big Tech
Dec 23, 2025 by
CPI
Google Sues Alleged China-Based Hackers Over Widespread Phishing Scheme
Dec 22, 2025 by
CPI
Europe Moves to Clarify What Counts as Personal Data
Dec 22, 2025 by
CPI
Larry Ellison Offers $40 Billion Guarantee as Paramount Renews Bid for Warner Bros
Dec 22, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 16, 2025 by
CPI
Learning from Divergence: The Role of Cross-Country Comparisons in the Evaluation of the DMA
Dec 16, 2025 by
Federico Bruni
New Regulatory Tools for the EU Foreign Direct Investment Screening and Foreign Subsidies Regulation
Dec 16, 2025 by
Ioannis Kokkoris
“Suite Dreams”: Market Definition and Complementarity in the Digital Age
Dec 16, 2025 by
Romain Bizet & Matteo Foschi
The Interaction Between Competition Policy and Consumer Protection: Institutional Design, Behavioral Insights, and Emerging Challenges in Digital Markets
Dec 16, 2025 by
Alessandra Tonazzi